Werbung
Kiniksa Pharmaceuticals Aktie Analyse
| 11.03.19 | Kiniksa Pharmaceuticals overweight | Barclays Capital | |
| 12.12.18 | Kiniksa Pharmaceuticals Outperform | Wedbush Morgan Securities Inc. |
Werbung
Werbung